NCT04472962

Brief Summary

This study is a clinical, randomized, crossover study. The study investigates the effect of a low-carbohydrate-high-protein pre-exercise meal on preventing exercise-induced hypoglycemia in people with type 1 diabetes. The hypothesis is that intake of a low-carbohydrate-high-protein meal can reduce the duration and depth of hypoglycemia during and after exercise in people with type 1 diabetes compared with an isocaloric high-carbohydrate-low-protein meal with identical fat content. The study will contribute with new knowledge about importance of meal composition on preventing exercise-induced hypoglycemia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 24, 2020

Completed
22 days until next milestone

First Posted

Study publicly available on registry

July 16, 2020

Completed
29 days until next milestone

Study Start

First participant enrolled

August 14, 2020

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2021

Completed
Last Updated

February 15, 2021

Status Verified

December 1, 2020

Enrollment Period

6 months

First QC Date

June 24, 2020

Last Update Submit

February 12, 2021

Conditions

Keywords

ExerciseNutritionHypoglycemia

Outcome Measures

Primary Outcomes (1)

  • The area over the curve (AOC).

    The primary outcome measure is the AOC for plasma glucose (PG) \< 3.9 mmol/L during the in-clinic period assessed by YSI (Yellow Spring Instruments 2900 STAT Plus). The AOC is the area, which extends from the plasma glucose curve to the limit for hypoglycemia \< 3.9 mmol/l.

    7 hours.

Secondary Outcomes (44)

  • Time spent < 3.9 mmol/l during in-clinic period, home period and overall study period assessed by CGM.

    7, 17 and 24 hours respectively.

  • Time spent < 3.9 mmol/l during in-clinic period assessed by YSI.

    7 hours.

  • Time spent 3.0-3.8 mmol/l during in-clinic period, home period, and overall study period assessed by CGM.

    7, 17 and 24 hours respectively.

  • Time spent 3.0-3.8 mmol/l during in-clinic period assessed by YSI.

    7 hours.

  • Time spent < 3.0 mmol/l during in-clinic period, home period, and overall study period assessed by CGM.

    7, 17 and 24 hours respectively.

  • +39 more secondary outcomes

Study Arms (2)

Low-carbohydrate-high-protein pre-exercise meal

ACTIVE COMPARATOR
Other: Pre-exercise meal

High-carbohydrate-low-protein pre-exercise meal

ACTIVE COMPARATOR
Other: Pre-exercise meal

Interventions

Mixed meal with low-carbohydrate-high-protein content

Low-carbohydrate-high-protein pre-exercise meal

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18-70 years.
  • Type 1 diabetes ≥ 5 years.
  • Insulin pump use ≥ 1 year.
  • Use of flash glucose monitoring (FGM) or continuous glucose monitoring (CGM) ≥ 3 months.
  • Body mass index 18.5-30 kg/m2.
  • HbA1c ≤ 64 mmol/mol (8.0%).
  • Self-reported hypoglycemia awareness
  • Ability to carbohydrate count for all meals.
  • Familiarity with the insulin pump bolus calculator for all meals.
  • Moderate to vigorous level of physical activity

You may not qualify if:

  • Use of anti-diabetic medicine (other than insulin), corticosteroids or other drugs affecting glucose metabolism during the study period or within 30 days prior to study start.
  • Use of Metronic Minimed 670G insulin pump system.
  • Allergy to paracetamol or nuts
  • Females who are pregnant, breast-feeding or intend to become pregnant.
  • Heart disease.
  • Severe asthma.
  • Other concomitant medical or psychological condition that according to the investigator's assessment makes the individual unsuitable for study participation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Steno Diabetes Center Copenhagen

Gentofte Municipality, 2820, Denmark

Location

Related Publications (2)

  • Kristensen KB, Ranjan AG, McCarthy OM, Holst JJ, Bracken RM, Norgaard K, Schmidt S. Effects of a Low-Carbohydrate-High-Protein Pre-Exercise Meal in Type 1 Diabetes-a Randomized Crossover Trial. J Clin Endocrinol Metab. 2023 Dec 21;109(1):208-216. doi: 10.1210/clinem/dgad427.

  • McCarthy OM, Kristensen KB, Christensen MB, Schmidt S, Ranjan AG, Nicholas C, Bain SC, Norgaard K, Bracken R. Metabolic and physiological responses to graded exercise testing in individuals with type 1 diabetes using insulin pump therapy. Diabetes Obes Metab. 2023 Mar;25(3):878-888. doi: 10.1111/dom.14938. Epub 2023 Jan 3.

MeSH Terms

Conditions

Diabetes Mellitus, Type 1Motor ActivityHypoglycemia

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System DiseasesBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 24, 2020

First Posted

July 16, 2020

Study Start

August 14, 2020

Primary Completion

January 30, 2021

Study Completion

January 30, 2021

Last Updated

February 15, 2021

Record last verified: 2020-12

Data Sharing

IPD Sharing
Will not share

Locations